Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on November 4, 2021. The report covers the month of November 2021 and serves to disseminate a press release dated November 4, 2021, to U.S. investors.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a financial statement.
Material Changes
The filing text does not contain data regarding material changes versus prior comparable periods. The content is limited to the submission of a press release exhibit.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed within the body of this Form 6-K. The filing references a press release (Exhibit 99.1) which likely contains these details, but the text of the press release is not included in the provided input.
Key Facts for Investor Verification
- Verify the content of the press release dated November 4, 2021, referenced as Exhibit 99.1, as the Form 6-K itself contains no operational or financial data.
- Confirm the company's status as a registrant filing under Form 20-F.
- Note that the report was signed by André Choulika, Chief Executive Officer.